Occurrence of Pancytopenia Among Patients With Cancer Treated With Poly(Adenosine Diphosphate-Ribose) Polymerase Inhibitors: A Pharmacoepidemiologic Study.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 34647977.
- Also identified by DOI 10.1001/jamaoncol.2021.4672 and PMC identifier 8517880.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cross-sectional study uses pharmacovigilance data to investigate the occurrence of pancytopenia among patients with cancer treated with poly(adenosine diphosphate–ribose) polymerase inhibitors and examines the clinical features of pancytopenia related to these drugs.
Medical subject headings
- Neoplasms
- Pancytopenia